Cutaneous toxicities associated with epidermal growth factor receptor (EGFR) and mesenchymal epithelial transition factor (MET) dual blockade via bispecific antibody amivantamab [0.03%]
双特异性抗体amivantamab联合阻断表皮生长因子受体（EGFR）和间质上皮转化因子（MET）的皮肤毒性反应
Isabel Arana,Grant J Riew,Adam Rock et al.
Isabel Arana et al.
Risk of developing sleep disorders and psychologic comorbidity in children with inflammatory skin diseases - a population-based study [0.03%]
儿童炎症性皮肤病患者出现睡眠障碍和心理共病的风险——一项基于人口的调查研究
Caroline Mann,Andreas Wollenberg,Sascha Ständer et al.
Caroline Mann et al.
Background: Inflammatory skin diseases such as atopic dermatitis (AD), psoriasis and urticaria are associated with impaired mental health and sleep. In children the risk of developing these comorbidities is still poorly e...
An International Multicenter, Retrospective Cohort Study of 203 Patients with Pediatric Androgenetic Alopecia [0.03%]
儿童雄激素性脱发的国际多中心回顾队列研究（203例）
Tyan Shin Lee,Mara O&#x;Connor,Leslie Castelo-Soccio et al.
Tyan Shin Lee et al.
Background: Androgenetic alopecia (AGA) is a nonscarring alopecia with increasing prevalence in pediatric populations. Published data in pediatrics is limited. ...
Risk of metastasis at presentation and disease-specific death for desmoplastic and spindle cell melanoma: a SEER database analysis [0.03%]
基于SEER数据库的解脲支原体阳性对黑色素瘤患者诊断时发生转移和疾病特异性死亡的影响分析
Frederick T Gibson,Nina A Ran,Chrysalyne D Schmults et al.
Frederick T Gibson et al.
Association of cutaneous immune-related adverse events with improved overall survival among patients with cutaneous squamous cell carcinoma treated with palliative PD-1 inhibition [0.03%]
免疫检查点抑制剂治疗皮肤鳞状细胞癌的患者中皮肤免疫相关不良事件与总生存期改善的关系：一项回顾性研究
Frederick T Gibson,Nina A Ran,Ann W Silk et al.
Frederick T Gibson et al.
Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: further analysis of the DESIRES trial [0.03%]
利妥昔单抗治疗系统性硬化症相关间质性肺病的疗效：DESIRES试验进一步分析
Ai Kuzumi,Satoshi Ebata,Murray Baron et al.
Ai Kuzumi et al.
Bullous Pemphigoid: A practical approach to diagnosis and management in the modern era [0.03%]
实践中的 bullous pemphigoid：现代诊断和治疗要点
Camille M Powers,Sach Thakker,Nicholas Gulati et al.
Camille M Powers et al.
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder, primarily presenting with tense bullae and severe pruritus. Diagnosing and treating BP can be challenging due to its variable clinical presentations. We...
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study [0.03%]
阿普西替尼治疗中重度汗腺炎的疗效：一项2期随机安慰剂对照研究结果
Lindsay S Ackerman,Bethanee J Schlosser,Tianyu Zhan et al.
Lindsay S Ackerman et al.
Background: Hidradenitis suppurativa (HS) is a disabling inflammatory skin disease. Objective: To investigate the efficacy and safety o...
Updated Expert Opinion Guidelines Regarding the Effects of Immunosuppressive Agents on Patch Testing [0.03%]
关于免疫抑制剂对斑贴试验影响的专家意见指南更新
Mykayla Sandler,Brandon L Adler,Amber R Atwater et al.
Mykayla Sandler et al.